GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » RaySearch Laboratories AB (OSTO:RAY B) » Definitions » Cyclically Adjusted FCF per Share

RaySearch Laboratories AB (OSTO:RAY B) Cyclically Adjusted FCF per Share : kr6.96 (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is RaySearch Laboratories AB Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

RaySearch Laboratories AB's adjusted free cash flow per share for the three months ended in Mar. 2024 was kr3.106. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr6.96 for the trailing ten years ended in Mar. 2024.

During the past 12 months, RaySearch Laboratories AB's average Cyclically Adjusted FCF Growth Rate was 14.50% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 16.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 20.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of RaySearch Laboratories AB was 24.00% per year. The lowest was 16.50% per year. And the median was 21.00% per year.

As of today (2024-06-19), RaySearch Laboratories AB's current stock price is kr141.60. RaySearch Laboratories AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was kr6.96. RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF of today is 20.34.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of RaySearch Laboratories AB was 68.64. The lowest was 8.05. And the median was 19.54.


RaySearch Laboratories AB Cyclically Adjusted FCF per Share Historical Data

The historical data trend for RaySearch Laboratories AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RaySearch Laboratories AB Cyclically Adjusted FCF per Share Chart

RaySearch Laboratories AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.44 4.23 4.99 5.81 6.68

RaySearch Laboratories AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.08 6.24 6.51 6.68 6.96

Competitive Comparison of RaySearch Laboratories AB's Cyclically Adjusted FCF per Share

For the Health Information Services subindustry, RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF falls into.



RaySearch Laboratories AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, RaySearch Laboratories AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=3.106/132.2054*132.2054
=3.106

Current CPI (Mar. 2024) = 132.2054.

RaySearch Laboratories AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.208 100.432 0.274
201409 0.259 100.161 0.342
201412 0.649 100.225 0.856
201503 0.675 99.950 0.893
201506 0.567 99.995 0.750
201509 0.380 100.228 0.501
201512 1.190 100.276 1.569
201603 0.640 100.751 0.840
201606 0.434 101.019 0.568
201609 0.297 101.138 0.388
201612 2.160 102.022 2.799
201703 1.154 102.022 1.495
201706 0.753 102.752 0.969
201709 1.040 103.279 1.331
201712 1.365 103.793 1.739
201803 1.634 103.962 2.078
201806 0.429 104.875 0.541
201809 -0.376 105.679 -0.470
201812 3.518 105.912 4.391
201903 1.465 105.886 1.829
201906 3.994 106.742 4.947
201909 1.510 107.214 1.862
201912 2.367 107.766 2.904
202003 1.927 106.563 2.391
202006 3.951 107.498 4.859
202009 2.289 107.635 2.812
202012 1.502 108.296 1.834
202103 3.043 108.360 3.713
202106 1.694 108.928 2.056
202109 1.381 110.338 1.655
202112 0.828 112.486 0.973
202203 3.650 114.825 4.202
202206 0.355 118.384 0.396
202209 -0.966 122.296 -1.044
202212 1.847 126.365 1.932
202303 2.964 127.042 3.084
202306 0.314 129.407 0.321
202309 2.354 130.224 2.390
202312 1.493 131.912 1.496
202403 3.106 132.205 3.106

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


RaySearch Laboratories AB  (OSTO:RAY B) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=141.60/6.96
=20.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of RaySearch Laboratories AB was 68.64. The lowest was 8.05. And the median was 19.54.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


RaySearch Laboratories AB Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of RaySearch Laboratories AB's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


RaySearch Laboratories AB (OSTO:RAY B) Business Description

Traded in Other Exchanges
Address
Sveavagen 44, P.O. Box 3297, Stockholm, SWE, 103 65
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia, Europe and the rest of the world. The company generates majority of its sales from the North America.

RaySearch Laboratories AB (OSTO:RAY B) Headlines

No Headlines